Why all pharmaceutical research should be made open access | Cory Doctorow | Technology | The Guardian

peter.suber's bookmarks 2019-03-14

Summary:

"That's why Goldacre's work is important to this discussion. The reason pharma companies should be required to publish their results isn't that they've received a public subsidy for the research. Rather, it is because they are asking for a governmental certification saying that their products are fit for consumption, and they are asking for regulatory space to allow doctors to write prescriptions for those products. We need them to disclose their research – even if doing so undermines their profits – because without that research, we can't know if their products are fit for use...."

Link:

https://www.theguardian.com/technology/2012/nov/20/pharmaceutical-research-open-access

Updated:

03/14/2019, 13:18

From feeds:

Open Access Tracking Project (OATP) » peter.suber's bookmarks

Tags:

oa.pharma oa.mandates oa.recommendations oa.medicine oa.usa oa.patents oa.policies oa.industry

Date tagged:

03/14/2019, 17:17

Date published:

11/20/2012, 12:18